Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta‐analysis

Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta‐analysis

Abstract Background The clinical value of cardiopulmonary exercise testing (CPET) in cardiac amyloidosis (CA) is uncertain. Due to the growing prevalence of the disease and the current availability of disease‐modifying drugs, prognostic stratification is becoming fundamental to optimizing the cost‐e...

Full description

Bibliographic Details
Main Authors: Anna Cantone, Matteo Serenelli, Federico Sanguettoli, Daniele Maio, Gioele Fabbri, Beatrice Dal Passo, Piergiuseppe Agostoni, Giovanni Grazzi, Gianluca Campo, Claudio Rapezzi
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:ESC Heart Failure
Subjects:
Amyloidosis
CPET
Heart failure
Mortality
VO2 peak
VE/VCO slope
Online Access:https://doi.org/10.1002/ehf2.14406

Internet

https://doi.org/10.1002/ehf2.14406

Similar Items